{"id":52590,"date":"2021-07-30T10:32:00","date_gmt":"2021-07-30T10:32:00","guid":{"rendered":"https:\/\/www.verificat.cat\/coviran-barekat-comme-fonctionne\/"},"modified":"2021-07-30T10:32:00","modified_gmt":"2021-07-30T10:32:00","slug":"coviran-barekat-comme-fonctionne","status":"publish","type":"post","link":"https:\/\/www.verificat.cat\/fr\/coviran-barekat-comme-fonctionne\/","title":{"rendered":"COVIran Barekat"},"content":{"rendered":"<p><br \/>\n<\/p>\n<p>COVIran Barekat est le premier vaccin mis au point en Iran &agrave; &ecirc;tre<a href=\"https:\/\/covid19.trackvaccines.org\/country\/iran-islamic-republic-of\/\" target=\"_blank\" rel=\"noopener\"> approuv&eacute;<\/a>. Il s&rsquo;agit d&rsquo;un vaccin &agrave;<a href=\"https:\/\/www.verificat.cat\/infografia\/tipus-de-vacunes\" target=\"_blank\" rel=\"noopener\"> virus inactiv&eacute;<\/a>, mis au point par l&rsquo;entreprise pharmaceutique Shiga Pharmed Industrial CO, qui utilise une version morte du virus qui cause la maladie, et qui est donc incapable d&rsquo;infecter, mais peut d&eacute;clencher une r&eacute;ponse immunitaire.<\/p>\n<p>Les<a href=\"https:\/\/www.biorxiv.org\/content\/10.1101\/2021.06.10.447951v1.full.pdf\" target=\"_blank\" rel=\"noopener\"> &eacute;tudes pr&eacute;cliniques<\/a> auxquelles ce vaccin a &eacute;t&eacute; soumis ont donn&eacute; des r&eacute;sultats &laquo; appropri&eacute;s en termes de s&eacute;curit&eacute; et d&rsquo;efficacit&eacute; &raquo;, ouvrant ainsi la voie aux essais cliniques chez l&rsquo;&ecirc;tre humain.<\/p>\n<p>Les &eacute;tudes de<a href=\"https:\/\/irct.ir\/trial\/52701\" target=\"_blank\" rel=\"noopener\"> phase I<\/a> ont commenc&eacute; fin 2020, avec un &eacute;chantillon de 56 volontaires, et ont &eacute;t&eacute; suivies des &eacute;tudes de<a href=\"https:\/\/en.irct.ir\/trial\/54881\" target=\"_blank\" rel=\"noopener\"> phases II\/III<\/a>, sur un total de 20 000 personnes, selon le registre iranien des essais cliniques. Les r&eacute;sultats officiels de ces essais n&rsquo;ont pas encore &eacute;t&eacute; publi&eacute;s, et on ne dispose pas non plus de communiqu&eacute; analysant l&rsquo;efficacit&eacute; du vaccin.<\/p>\n<p>La vaccination par COVIran Barekat comporte deux doses &agrave; administrer &agrave; un intervalle de 28 jours. Aucune information n&rsquo;a &eacute;t&eacute; publi&eacute;e concernant la temp&eacute;rature de stockage.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>COVIran Barekat est le premier vaccin mis au point en  [&#8230;]<\/p>\n","protected":false},"author":15,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[170],"tags":[209],"class_list":["post-52590","post","type-post","status-publish","format-standard","hentry","category-non-classifiee","tag-vaccines-fr","vc-legacy-post"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.verificat.cat\/fr\/wp-json\/wp\/v2\/posts\/52590","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.verificat.cat\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.verificat.cat\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.verificat.cat\/fr\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/www.verificat.cat\/fr\/wp-json\/wp\/v2\/comments?post=52590"}],"version-history":[{"count":0,"href":"https:\/\/www.verificat.cat\/fr\/wp-json\/wp\/v2\/posts\/52590\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.verificat.cat\/fr\/wp-json\/wp\/v2\/media?parent=52590"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.verificat.cat\/fr\/wp-json\/wp\/v2\/categories?post=52590"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.verificat.cat\/fr\/wp-json\/wp\/v2\/tags?post=52590"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}